The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: An Adaptive Study to Match Patients With Solid Tumors to Various Immunotherapy Combinations Based Upon a Broad Biomarker Assessment
Official Title: ADaptiVe Biomarker Trial That InformS Evolution of Therapy
Study ID: NCT03335540
Brief Summary: The purpose of this study is to evaluate the treatment of solid tumors with various immunotherapy combinations. The treatment will be determined based upon a broad biomarker assessment.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Local Institution - 0001, Chicago, Illinois, United States
University of Chicago, Chicago, Illinois, United States
Local Institution - 0002, Baltimore, Maryland, United States
Local Institution - 0003, Pittsburgh, Pennsylvania, United States
Name: Bristol-Myers Squibb
Affiliation: Bristol-Myers Squibb
Role: STUDY_DIRECTOR